Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma

Cited by (811)

Items 401–500 of 811

  1. TET2–STAT3–CXCL5 nexus promotes neutrophil lipid transfer to fuel lung adeno-to-squamous transition
    Yun Xue, Yuting Chen, Sijia Sun, Xinyuan Tong, Yujia Chen, Shijie Tang, Xue Wang, Simin Bi, Yuqin Qiu, Qiqi Zhao et al. · 2024 · The Journal of Experimental Medicine
  2. Merkel cell carcinoma expresses vasculogenic mimicry: demonstration in patients and experimental manipulation in xenografts
    Cecilia M. Lezcano, Sonja Kleffel, Nayoung Lee, Allison R. Larson, Qian Zhan, Andrew A. Dorosario, Linda C. Wang, Tobias Schatton, Gëorge F. Murphy · 2014 · Laboratory Investigation
  3. Epigenetics of T lymphocytes in health and disease
    Cristina Leoni, Lucia Vincenzetti, Stefan Emming, Silvia Monticelli · 2015 · Swiss Medical Weekly
  4. IDH1/2 Mutants Inhibit TET-Promoted Oxidation of RNA 5mC to 5hmC
    Qiang Xu, Kai Wang, Lina Wang, Yuting Zhu, Guangyu Zhou, Dan Xie, Qingkai Yang · 2016 · PLoS ONE
  5. Thioether Macrocyclic Peptides Selected against TET1 Compact Catalytic Domain Inhibit TET1 Catalytic Activity
    Kosuke Nishio, Roman Belle, Takayuki Katoh, Akane Kawamura, Toru Sengoku, Kazuharu Hanada, Noboru Ohsawa, Mikako Shirouzu, Shigeyuki Yokoyama, Hiroaki Suga · 2018 · ChemBioChem
  6. Global distribution of DNA hydroxymethylation and DNA methylation in chronic lymphocytic leukemia
    Sara Wernig-Zorc, Mukesh Pratap Yadav, Pradeep Kumar Kopparapu, Mats Bemark, Hallgerdur Lind Kristjansdottir, Per‐Ola Andersson, Chandrasekhar Kanduri, Meena Kanduri · 2019 · Epigenetics & Chromatin
  7. Update on melanoma epigenetics
    Blanca de Unamuno, Sarai Palanca, Rafael Botella · 2015 · Current Opinion in Oncology
  8. DNA 5-hydroxymethylcytosine in pediatric central nervous system tumors may impact tumor classification and is a positive prognostic marker
    Nasim Azizgolshani, Curtis Lee Petersen, Youdinghuan Chen, Joshua Levy, Lucas A. Salas, Laurent Perreard, Lananh Nguyen, Brock C. Christensen · 2021 · Clinical Epigenetics
  9. Epigenetic mechanisms of tumorigenicity manifesting in stem cells
    P. X. Tung, Paul S. Knoepfler · 2014 · Oncogene
  10. The promoter methylomes of monochorionic twin placentas reveal intrauterine growth restriction-specific variations in the methylation patterns
    Zhiming He, Hanlin Lu, Huijuan Luo, Fei Gao, Tong Wang, Yu Gao, Qun Fang, Junwen Wang · 2016 · Scientific Reports
  11. 5-Hydroxymethylcytosine preferentially targets genes upregulated in isocitrate dehydrogenase 1 mutant high-grade glioma
    Wioletta K. Glowacka, Harshika Jain, Makiko Kunogi Okura, Abulizi Maimaitiming, Yasin Mamatjan, Romina Nejad, Hamza Farooq, Michael D. Taylor, Kenneth Aldape, Paul N. Kongkham · 2018 · Acta Neuropathologica
  12. TET1-mediated DNA hypomethylation regulates the expression of MUC4 in lung cancer
    Seiya Yokoyama, Michiyo Higashi, Hideaki Tsutsumida, J. Wakimoto, Tomofumi Hamada, Edwin Wiest, Kei Matsuo, Ikumi Kitazono, Yuko Goto, Xin Guo et al. · 2017 · Genes & Cancer
  13. Loss of Thymine DNA Glycosylase Causes Dysregulation of Bile Acid Homeostasis and Hepatocellular Carcinoma
    Haider M. Hassan, Majdina Isovic, Bart Kolendowski, Natasha Bauer-Maison, Oladapo Onabote, Matthew J. Cecchini, Aaron R. Haig, Saman Maleki Vareki, T. Michael Underhill, Joseph Torchia · 2020 · Cell Reports
  14. The role of TET family proteins and 5-hydroxymethylcytosine in human tumors.
    Yi‐Chen Wu, Zhi‐Qiang Ling · 2014 · PubMed
  15. MXene Boosted Ultrasensitive Electrochemical Detection of 5‐Hydroxymethylcytosine in Genomic DNA from Complex Backgrounds
    Zhenzhen Xu, Zhigang Wang, Dingmeng Hu, Huiqin Chen, Yufei Yan, Yuan Li, Mengjing Tu, Qiaofeng Shen, Xuanyi Liu, Rui Li et al. · 2024 · Advanced Functional Materials
  16. Epigenetics and Ultraviolet Radiation: Implications for Skin Ageing and Carcinogenesis
    Bethany M. Barnes, Anya Shyne, David Andrew Gunn, Christopher E.M. Griffiths, Rachel E. B. Watson · 2024 · Skin Health and Disease
  17. Zinc Finger Protein 618 Regulates the Function of UHRF2 (Ubiquitin-like with PHD and Ring Finger Domains 2) as a Specific 5-Hydroxymethylcytosine Reader
    Yidan Liu, Bin Zhang, Henry Kuang, Gautam Korakavi, Lin‐Yu Lu, Xiaochun Yu · 2016 · Journal of Biological Chemistry
  18. 5‐Hydroxymethylcytosine is a nuclear biomarker to assess biological potential in histologically ambiguous heavily pigmented melanocytic neoplasms
    Jonathan J. Lee, Ricardo E. Vilain, Scott R. Granter, Nina R. Hu, Scott C. Bresler, Shuyun Xu, Alexander Frank, Martín C. Mihm, Robyn P.M. Saw, Christopher D.�M. Fletcher et al. · 2016 · Journal of Cutaneous Pathology
  19. Decrease of 5-hydroxymethylcytosine and TET1 with nuclear exclusion of TET2 in small intestinal neuroendocrine tumors
    Elham Barazeghi, Surendra Prabhawa, Olov Norlén, Per Hellman, Peter L. H. Stalberg, Gunnar Westin · 2018 · BMC Cancer
  20. Eicosapentaenoic acid induces DNA demethylation in carcinoma cells through a TET1‐dependent mechanism
    Veronica Ceccarelli, Virginia Valentini, Simona Ronchetti, Lorenza Cannarile, Monia Billi, Carlo Riccardi, Laura Ottini, Vincenzo Nicola Talesa, Francesco Grignani, Alba Vecchini · 2018 · The FASEB Journal
  21. Molecular Testing for Cutaneous Melanoma: An Update and Review
    Jonathan J. Lee, Christine Guo Lian · 2018 · Archives of Pathology & Laboratory Medicine
  22. Thyroid Hormone Induces DNA Demethylation in Xenopus Tadpole Brain
    Samhitha Raj, Yasuhiro Kyono, Christopher J. Sifuentes, Elvira del Carmen Arellanes-Licea, Arasakumar Subramani, Robert J. Denver · 2020 · Endocrinology
  23. Role of Biomarkers in the Integrated Management of Melanoma
    Piyu Parth Naik · 2021 · Disease Markers
  24. Pathway,in silicoand tissue-specific expression quantitative analyses of oesophageal squamous cell carcinoma genome-wide association studies data
    Paula L. Hyland, Han Zhang, Qi Yang, Howard Hua Yang, Nan Hu, Shih‐Wen Lin, Hua Su, Lemin Wang, Chaoyu Wang, Ti Ding et al. · 2015 · International Journal of Epidemiology
  25. The role of TET-mediated DNA hydroxymethylation in prostate cancer
    Elien Smeets, Andy G. Lynch, Stefan Preković, Thomas Van den Broeck, Lisa Moris, Christine Helsen, Steven Joniau, Frank Claessens, Charlie E. Massie · 2017 · Molecular and Cellular Endocrinology
  26. Epigenetic Regulation in Uterine Fibroids—The Role of Ten-Eleven Translocation Enzymes and Their Potential Therapeutic Application
    Marta Włodarczyk, Grażyna Nowicka, Michał Ciebiera, Mohamed K. Ali, Qiwei Yang, Ayman A. Al-Hendy · 2022 · International Journal of Molecular Sciences
  27. Evaluation of stromal HGF immunoreactivity as a biomarker for melanoma response to RAF inhibitors
    Cecilia M. Lezcano, Chung‐Wei Lee, Allison R. Larson, Alexander Maxwell Menzies, Richard F. Kefford, John F. Thompson, Martín C. Mihm, Shuji Ogino, Georgina Venetia Long, Richard A. Scolyer et al. · 2014 · Modern Pathology
  28. Physiological and pathological implications of 5-hydroxymethylcytosine in diseases
    Jing Liang, Fan Yang, Liang Zhao, Chongwei Bi, Benzhi Cai · 2016 · Oncotarget
  29. Medulloblastoma and ependymoma cells display increased levels of 5-carboxylcytosine and elevated TET1 expression
    Ashley H. Ramsawhook, Lara C. Lewis, Beth Coyle, Alexey S. Ruzov · 2017 · Clinical Epigenetics
  30. The level and clinical significance of 5-hydroxymethylcytosine in oral squamous cell carcinoma: An immunohistochemical study in 95 patients
    Yi Wang, Huijun Hu, Qiong Wang, Zhongwu Li, Yumin Zhu, Wei Zhang, Yanling Wang, Hongbing Jiang, Jie Cheng · 2017 · Pathology - Research and Practice
  31. TET1 inhibits cell proliferation by inducing RASSF5 expression
    Bo-Tai Li, Chao Yuan Yu, Ying Xu, Shengbing Liu, Heng‐Yu Fan, Weiwei Pan · 2017 · Oncotarget
  32. Endogenously generated DNA nucleobase modifications source, and significance as possible biomarkers of malignant transformation risk, and role in anticancer therapy
    Ryszard Oliński, Daniel Gackowski, Marcus S. Cooke · 2017 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
  33. DNA Methylation and Hydroxymethylation in Primary Colon Cancer and Synchronous Hepatic Metastasis
    Silvia Udali, Domenica De Santis, Andrea Ruzzenente, Sara Moruzzi, Filippo Mazzi, Greta Beschin, Stephanie A. Tammen, Tommaso Campagnaro, Patrizia Pattini, Oliviero Olivieri et al. · 2018 · Frontiers in Genetics
  34. Loss of 5-Hydroxymethylcytosine is an Epigenetic Hallmark of Thyroid Carcinomas with TERT Promoter Mutations
    Naoki Oishi, Huy Gia Vuong, Kunio Mochizuki, Tetsuo Kondo · 2020 · Endocrine Pathology
  35. Quantification of Epigenetic DNA Modifications in the Subchromatin Structure Matrix Attachment Regions by Stable Isotope Dilution UHPLC-MS/MS Analysis
    Rui Zhang, Weiyi Lai, Hailin Wang · 2021 · Analytical Chemistry
  36. Deoxyribonucleic Acid 5-Hydroxymethylation in Cell-Free Deoxyribonucleic Acid, a Novel Cancer Biomarker in the Era of Precision Medicine
    Ling Xu, Yixin Zhou, Lijie Chen, Abdul Saad Bissessur, Jida Chen, Misha Mao, Siwei Ju, Lini Chen, Cong Chen, Zhaoqin Li et al. · 2021 · Frontiers in Cell and Developmental Biology
  37. Hypermethylation of TET1 Promoter Is a New Diagnosic Marker for Breast Cancer Metastasis
    Yi Sang, Chun Cheng, Xiaofeng Tang, Meifang Zhang, Xiaobin Lv · 2015 · Asian Pacific Journal of Cancer Prevention
  38. Blood DNA methylation, nevi number, and the risk of melanoma
    Laura Pergoli, Chiara Favero, Ruth M. Pfeiffer, Letizia Tarantini, Donato Calista, Tommaso Cavalleri, Laura Angelici, Dario Consonni, Pier Alberto Bertazzi, Angela Cecilia Pesatori et al. · 2014 · Melanoma Research
  39. Reversal of TET-mediated 5-hmC loss in hypoxic fibroblasts by ascorbic acid
    Yukun Liu, Shuyun Xu, Tingjian Zu, Feng Li, Shengbo Sang, Cynthia Liu, Yang An, Bobin Mi, Dennis Paul Orgill, George F. Murphy et al. · 2019 · Laboratory Investigation
  40. Epigenetic Therapies in Melanoma—Targeting DNA Methylation and Histone Modification
    Adrian Bogdan Țigu, Andrei Ivancuta, Andrada Uhl, Alexandru Cristian Sabo, Mădălina Nistor, Ximena Maria Mureșan, Diana Cenariu, Tanase Timis, Doru Mihai Diculescu, Diana Gulei · 2025 · Biomedicines
  41. Expression of the methylcytosine dioxygenase ten-eleven translocation-2 and connexin 43 in inflammatory bowel disease and colorectal cancer
    Mohammad El-Harakeh, Jessica L. Saliba, Kawthar Sharaf Aldeen, May Haidar, Layal El‐Hajjar, Mireille Kallassy Awad, Jana G. Hashash, Margret Shirinian, Marwan Eid El-Sabban · 2022 · World Journal of Gastroenterology
  42. Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia
    Zhenhua Chen, Keren Zhou, Jianhuang Xue, Andrew Small, Gang Xiao, Le Xuan Truong Nguyen, Zheng Zhang, Emily A. Prince, Hengyou Weng, Huilin Huang et al. · 2023 · Science Translational Medicine
  43. Loss of the epigenetic mark, 5-Hydroxymethylcytosine, correlates with small cell/nevoid subpopulations and assists in microstaging of human melanoma
    Jonathan J. Lee, Martin G Cook, Martín C. Mihm, Shuyun Xu, Qian Zhan, Thomas J. Wang, Gëorge F. Murphy, Christine Guo Lian · 2015 · Oncotarget
  44. Urinary Measurement of Epigenetic DNA Modifications: A Non‐Invasive Assessment of the Whole‐Body Epigenetic Status in Healthy Subjects and Colorectal Cancer Patients
    Rafał Różalski, Daniel Gackowski, Agnieszka Siomek, Zbigniew Banaszkiewicz, Ryszard Oliński · 2016 · ChemistryOpen
  45. Multi-Omics Characterization of Inflammatory Bowel Disease-Induced Hyperplasia/Dysplasia in the Rag2−/−/Il10−/− Mouse Model
    Qiyuan Han, Thomas J. Y. Kono, Charles G. Knutson, Nicola M. Parry, Christopher L. Seiler, James G. Fox, Steven R. Tannenbaum, Natalia Y. Tretyakova · 2020 · International Journal of Molecular Sciences
  46. Genome-Wide 5-Hydroxymethylcytosine Profiling Analysis Identifies MAP7D1 as A Novel Regulator of Lymph Node Metastasis in Breast Cancer
    Shuang‐Ling Wu, Xiaoyi Zhang, Mengqi Chang, Changcai Huang, Jun Qian, Qing Li, Fang Yuan, Lihong Sun, Xinmiao Yu, Xinmiao Cui et al. · 2021 · Genomics Proteomics & Bioinformatics
  47. Sequencing the Cancer Methylome
    Austin Young Shull, Satish Kumar Reddy Noonepalle, Eun-Joon Lee, Jeong-Hyeon Choi, Huidong Shi · 2014 · Methods in molecular biology
  48. TET1 Depletion Induces Aberrant CpG Methylation in Colorectal Cancer Cells
    Masahiro Kai, Takeshi Niinuma, Hiroshi Kitajima, Eiichiro Yamamoto, Taku Harada, Hironori Aoki, Reo Maruyama, Mutsumi Toyota, Yasushi Sasaki, Tamotsu Sugai et al. · 2016 · PLoS ONE
  49. TET2 promotes tumor antigen presentation and T cell IFN-γ, which is enhanced by vitamin C
    Meng Cheng, Angel Ka Yan Chu, Zhijun Li, Shiyue Yang, Matthew D. Smith, Qi Zhang, Nicholas Gene Brown, William F. Marzluff, Nabeel M. Bardeesy, J. Justin Milner et al. · 2024 · JCI Insight
  50. Alterations of Epigenetic Signatures in Hepatocyte Nuclear Factor 4α Deficient Mouse Liver Determined by Improved ChIP-qPCR and (h)MeDIP-qPCR Assays
    Zhang, Qinghao, Lei, Xiaohong, Lu, Hong · 2014 · PLoS ONE
  51. Piecing together the puzzle: nanopore technology in detection and quantification of cancer biomarkers
    Trang Vu, Shanna-Leigh Davidson, Julia Borgesi, Maksudul Mowla, Tae‐Joon Jeon, Jiwook Shim · 2017 · RSC Advances
  52. TGF-β1-stimulation of matrix metalloproteinase-13 expression by down-regulation of miR-203a-5p in rat osteoblasts
    S. Saiganesh, R. Saathvika, Arumugam Balasubramanian, Vishal Mohanakrishnan, V. Udhaya, Rajangam Ilangovan, Nagarajan Selvamurugan · 2019 · International Journal of Biological Macromolecules
  53. Electrogenerated chemiluminescence biosensing method based on 5-hydroxymethylcytosine antibody and PDDA-CNTs nanocomposites for the determination of 5-hydroxymethylcytosine double-stranded DNA
    Yao Meng, Wanqiao Bai, Yuling Zhang, Huiping Sun, Yan Li · 2019 · Talanta
  54. Protonation–Suppression-Free LC-MS/MS Analysis for Profiling of DNA Cytosine Modifications in Adult Mice
    Jiezhen Mo, Ziyu Liang, Meiling Lü, Hailin Wang · 2020 · Analytical Chemistry
  55. The role of epigenetic modifications in Colorectal Cancer Metastasis
    Riya Su, Xinlin Wu, Liang Tao, Changshan Wang · 2022 · Clinical & Experimental Metastasis
  56. Quantitation and mapping of the epigenetic marker 5‐hydroxymethylcytosine
    Ying Qing, Zhiqi Tian, Ying Bi, Yongyao Wang, Jiangang Long, Chun‐Xiao Song, Jiajie Diao · 2017 · BioEssays
  57. Loss of UHRF2 Is Associated With Non-small Cell Lung Carcinoma Progression
    Chun Jin, Dian Xiong, Haoran Li, Jia-Hao Jiang, Jianchao Qi, Jian‐Yong Ding · 2018 · Journal of Cancer
  58. TET is targeted for proteasomal degradation by the PHD-pVHL pathway to reduce DNA hydroxymethylation
    Sijia Fan, Jing Wang, Guangqing Yu, Fangjing Rong, Dawei Zhang, Chenxi Xu, Juan Du, Zhi Li, Gang Ouyang, Wuhan Xiao · 2020 · Journal of Biological Chemistry
  59. 5-Hydroxymethylcytosine: a key epigenetic mark in cancer and chemotherapy response
    Suhas S. Kharat, Shyam K. Sharan · 2025 · Epigenetics & Chromatin
  60. Attenuation of genome-wide 5-methylcytosine level is an epigenetic feature of cutaneous malignant melanomas
    Goran Micevic, Nicholas Theodosakis, Janis Marie Taube, Marcus Bosenberg, Nemanja Rodić · 2016 · Melanoma Research
  61. miR-544 promotes maturity and antioxidation of stem cell-derived endothelial like cells by regulating the YY1/TET2 signalling axis
    Jianming Guo, Qiuling Xiang, Yaojie Xin, Yongyi Huang, Gang Zou, Te Liu · 2020 · Cell Communication and Signaling
  62. Personalized Epigenetics
    Michael Bitzer, N. P. Malek · 2016 · Elsevier eBooks
  63. Exome sequencing identifies frequent genomic loss of TET1 in IDH-wild-type glioblastoma
    Sebastian Stasik, Tareq Adnan Juratli, Andreas Petzold, Sven Richter, Amir Zolal, Gabriele Schackert, Andreas Dahl, Dietmar Krex, Christian Thiede · 2020 · Neoplasia
  64. Molecular characterization of fast-growing melanomas
    Caroline Gaudy‐Marqueste, Nicolas Macagno, Anderson Loundou, Eric Pellegrino, L’Houcine Ouafik, Timothy Budden, Piyushkumar A. Mundra, Gabriela Gremel, Victoria Akhras, Lijing Lin A et al. · 2021 · Journal of the American Academy of Dermatology
  65. Experimental and Bioinformatic Approaches to Studying DNA Methylation in Cancer
    Angelika Merkel, Manel Esteller · 2022 · Cancers
  66. Downregulation of IDH2 exacerbates the malignant progression of osteosarcoma cells via increased NF-κB and MMP-9 activation
    Wanrong Yi, Zonghuan Li, Baiwen Qi, Regis Ernest Mendame Ehya, Xiang Hu, Aixi Yu · 2016 · Oncology Reports
  67. Decreased 5-Hydroxymethylcytosine (5-hmC) predicts poor prognosis in early-stage laryngeal squamous cell carcinoma.
    Yanfang Zhang, Kexia Wu, Yuan Shao, Fang Sui, Qi Yang, Bingyin Shi, Peng Hou, Meiju Ji · 2016 · PubMed Central
  68. Scan_Tcga Tools for Integrated Epigenomic and Transcriptomic Analysis of Tumor Subgroups
    Aniruddha Chatterjee, Peter A. Stockwell, Euan James Rodger, Matthew F. Parry, Michael Roger Eccles · 2016 · Epigenomics
  69. Pitfalls and Opportunities for Epigenomic Analyses Focused on Disease Diagnosis, Prognosis, and Therapy
    Volker Martin Lauschke, Maxim Ivanov, Magnus Ingelman‐Sundberg · 2017 · Trends in Pharmacological Sciences
  70. Altered Global 5-Hydroxymethylation Status in Hidradenitis Suppurativa: Support for an Epigenetic Background
    Schapoor Hessam, Michael S. Sand, Kerstin Lang, Heiko Udo Käfferlein, Lisa Scholl, Thilo Gambichler, Marina Skrygan, Thomas Brüning, Eggert Stockfleth, Falk G. Bechara · 2017 · Dermatology
  71. Genome-wide characterization of cytosine-specific 5-hydroxymethylation in normal breast tissue
    Owen Michael Wilkins, Kevin C. Johnson, Eugene Andres Houseman, Jessica E. King, Carmen J. Marsit, Brock C. Christensen · 2019 · Epigenetics
  72. Nuclear localization of TET2 requires β-catenin activation and correlates with favourable prognosis in colorectal cancer
    Changpeng Li, Jingcai He, Fei Meng, Fuhui Wang, Hao Sun, Huizhong Zhang, Linna Dong, Mengdan Zhang, Qiaoran Xu, Lining Liang et al. · 2023 · Cell Death and Disease
  73. Biological significance of 5-hydroxymethylcytosine in oral epithelial dysplasia and oral squamous cell carcinoma
    Maria Cuevas‐Nunez, Camilla Borges Ferreira Gomes, Sook‐Bin Woo, Matthew R. Ramsey, Xiaoxin Luke Chen, Shuyun Xu, Ting Xu, Qian Zhan, Gëorge F. Murphy, Christine Guo Lian · 2017 · Oral Surgery Oral Medicine Oral Pathology and Oral Radiology
  74. The Impact of the HydroxyMethylCytosine epigenetic signature on DNA structure and function
    Federica Battistini, Pablo Daniel Dans, Montserrat Terrazas, Chiara Lara Castellazzi, Guillem Portella, Mireia Labrador, Núria Villegas, Isabelle Brun Heath, Carlos González, Modesto Orozco · 2021 · PLoS Computational Biology
  75. Role of DNA De-methylation intermediate ‘5-hydroxymethylcytosine’ in ovarian cancer management: A comprehensive review
    Deepa Bisht, Arisha Arora, Manisha Sachan · 2022 · Biomedicine & Pharmacotherapy
  76. Simple and cost-effective fluorescent labeling of 5-hydroxymethylcytosine
    Tamar Shahal, Ori Green, Uri Hananel, Yael Michaeli, Doron Shabat, Yuval Ebenstein · 2016 · Methods and Applications in Fluorescence
  77. The role of 5-hydroxymethylcytosine in melanoma
    Fengjuan Li, Liming Li, Ruihua Zhang, Cui Xu, Pan Zhou, Jia Long, Gang Hu, Ming-jun Jiang · 2017 · Melanoma Research
  78. Increased 5-hydroxymethylcytosine and Ten-eleven Translocation Protein Expression in Ultraviolet B-irradiated HaCaT Cells
    Dan Wang, Jinhua Huang, Qinghai Zeng, Can Gu, Shu Ding, Jianyun Lu, Jing Chen, Shengbo Yang · 2017 · Chinese Medical Journal
  79. Nichtkanonische Basen im Genom: die regulative Informationsebene in der DNA
    Thomas Carell, Matthias Q. Kurz, Markus Müller, Martin Rossa, Fabio Spada · 2017 · Angewandte Chemie
  80. Reduced hydroxymethylation characterizes medulloblastoma while TET and IDH genes are differentially expressed within molecular subgroups
    Karina Bezerra Salomão, Gustavo Alencastro Veiga Cruzeiro, Ricardo Bonfim-Silva, Lenisa Geron, Fernando Silva Ramalho, Fabiano Pinto Saggioro, Luciano Neder Serafini, Daniel Antunes Moreno, Rosane Gomes de Paula Queiróz, Simone dos Santos Aguiar et al. · 2018 · Journal of Neuro-Oncology
  81. Prognostic value of downregulated 5-hydroxymethylcytosine expression in renal cell carcinoma: a 10 year follow-up retrospective study
    Song Chen, Qiang Zhou, Tongzu Liu, Weibing Zhang, Xian‐Tao Zeng, Zhongqiang Guo · 2019 · Journal of Cancer
  82. Metabolic Reprogramming in Melanoma: An Epigenetic Point of View
    Sandro Giuliani, Celeste Accetta, Simona Di Martino, Claudia De Vitis, Elena Messina, Edoardo O. Pescarmona, Maurizio Fanciulli, Gennaro Ciliberto, Rita Mancini, Italia Falcone · 2025 · Pharmaceuticals
  83. Development of Novel Epigenetic Anti-Cancer Therapy Targeting TET Proteins
    Hyejin Kim, Inkyung Jung, Chan Hyeong Lee, Jungeun An, Myunggon Ko · 2023 · International Journal of Molecular Sciences
  84. Orthologous mammalian A3A-mediated single-nucleotide resolution sequencing of DNA epigenetic modification 5-hydroxymethylcytosine
    Xia Guo, Jianyuan Wu, Tong‐Tong Ji, Min Wang, Shan Zhang, Jun Xiong, Fang‐Yin Gang, Wei Liu, Yao-Hua Gu, Yu Liu et al. · 2025 · Chemical Science
  85. Nestin depletion induces melanoma matrix metalloproteinases and invasion
    Chung‐Wei Lee, Qian Zhan, Cecilia M. Lezcano, Markus H. Frank, John C. Huang, Allison R. Larson, Jennifer Y. Lin, Marilyn T. Wan, Ping‐I Lin, Jie Ma et al. · 2014 · Laboratory Investigation
  86. Global changes of 5-hydroxymethylcytosine and 5-methylcytosine from normal to tumor tissues are associated with carcinogenesis and prognosis in colorectal cancer
    Yiping Tian, Aifen Lin, Meifu Gan, Hao Wang, Dan Yu, Chong Lai, Dandan Zhang, Yimin Zhu, Maode Lai · 2017 · Journal of Zhejiang University SCIENCE B
  87. Global and gene-specific DNA methylation and hydroxymethylation in human skin exposed and not exposed to sun radiation
    Mikaelly Batista da Silva, Alanne Rayssa da Silva Melo, Ludimila de Araújo Costa, Haline Barroso, Naila Francis Paulo de Oliveira · 2017 · Anais Brasileiros de Dermatologia
  88. 树鼩大脑发育和老化过程中DNA去甲基化修饰的动态变化特征
    魏姝, Shu H. Wei, 华海蓉, 陈千权, 张莹, 陈菲, li shu qing, 李凡, 李家立, Hai-Rong Hua et al. · 2017 · 动物学研究
  89. Reduced ten-eleven translocation and isocitrate dehydrogenase expression in inflammatory hidradenitis suppurativa lesions
    Schapoor Hessam, Thilo Gambichler, Marina Skrygan, Michael S. Sand, Ines Rüddel, Lisa Scholl, Falk G. Bechara · 2018 · European Journal of Dermatology
  90. Interrogating Epigenome toward Personalized Approach in Cutaneous Melanoma
    Elena-Georgiana Dobre, Carolina Constantin, Marieta Costache, Monica Teodora Neagu · 2021 · Journal of Personalized Medicine
  91. Regulation of 5-Hydroxymethylcytosine by TET2 Contributes to Squamous Cell Carcinoma Tumorigenesis
    Rafik Boudra, Yvon Woappi, Diana Wang, Shuyun Xu, Michael Wells, Chrysalyne Delling Schmults, Christine Guo Lian, Matthew R. Ramsey · 2021 · Journal of Investigative Dermatology
  92. Cytosine modifications in myeloid malignancies
    Kristen M. Meldi, María E. Figueroa · 2015 · Pharmacology & Therapeutics
  93. Diagnostic utility of dual 5‐hydroxymethylcytosine/Melan‐A immunohistochemistry in differentiating nodal nevus from metastatic melanoma: An effective first‐line test for the workup of sentinel lymph node specimen
    Andrew B. Siref, Carissa A. Huynh, Bonnie Lei Balzer, David P. Frishberg, Richard Essner, Wonwoo Shon · 2019 · Journal of Cutaneous Pathology
  94. Highly Multiplexed 3D Profiling of Cell States and Immune Niches in Human Tumours
    Clarence Yapp, Ajit J. Nirmal, Felix Zhou, Alex Y. H. Wong, Juliann B. Tefft, Yi Daniel Lu, Zhiguo Shang, Zoltan Maliga, Paula D.L.M. Montero Llopis, Gëorge F. Murphy et al. · 2023 · bioRxiv (Cold Spring Harbor Laboratory)
  95. Landscape of TET2 Mutations: From Hematological Malignancies to Solid Tumors
    Zoë L. Hawking, James M. Allan · 2025 · Cancer Medicine
  96. Mutation of the Cell Cycle Regulator p27kip1 Drives Pseudohypoxic Pheochromocytoma Development
    Hermine Mohr, Simone Ballke, Nicole Bechmann, Sebastian Gulde, Jaber Malekzadeh‐Najafabadi, Mirko Peitzsch, Vasilis Ntziachristos, Katja Steiger, Tobias Wiedemann, Natalia Simona Pellegata · 2021 · Cancers
  97. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma
    Nien-Tzu Liu, Cherng‐Lih Perng, Yu‐Ching Chou, Pi-Shao Ko, Yi‐Jia Lin, Yu‐Chun Lin, Cheng‐Chang Chang, Yu‐Chi Wang, Hung‐Sheng Shang, Tai‐Kuang Chao · 2021 · PLoS ONE
  98. Epigenetic Regulation of Corneal Epithelial Differentiation by TET2
    Yuzuru Sasamoto, Siyuan Wu, Catherine A. A. Lee, Jason Jiang, Bruce R. Ksander, Markus H. Frank, Natasha Y. Frank · 2023 · International Journal of Molecular Sciences
  99. Exploring the role of epigenetic alterations and non-coding RNAs in melanoma pathogenesis and therapeutic strategies
    Marco Rubatto, Silvia Borriello, Nadia Sciamarrelli, Valentina Pala, Luca Tonella, Simone Ribero, Pietro Quaglino · 2023 · Melanoma Research
  100. Integrating 5hmC and gene expression data to infer regulatory mechanisms
    Cristina Mitrea, Priyanga Wijesinghe, Gregory E. Dyson, Adéle Kruger, Douglas Mark Ruden, Sorin Drăghici, Aliccia B. Bollig-Fischer · 2017 · Bioinformatics